Fresenius Kabi, France clinical trials
A country office of Fresenius Kabi
The registry lists 1 studies whose lead sponsor is Fresenius Kabi, France. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 12, 2024.
Registry sponsor names on this page
- Fresenius Kabi, France1 study
Something wrong with this grouping? Tell us on the Fresenius Kabi page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Fresenius Kabi studies →
- SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory DiseasesRecruitingNCT05598684
Sponsor listed in the registry: Fresenius Kabi, France